Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease : experience from the Phase 3 ATTRACT study

View/Open
Date
2019
Author
Type
URI
http://hdl.handle.net/10183/200996
Subject
In
American journal of medical genetics. Part A. Hoboken, N.J. : Wiley-Blackwell. Vol. 179A (2019), p. 1069–1073
Source
Foreign
Collections
 
   

This item is licensed under a Creative Commons License